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Abstract After cellular uptake, Copper (Cu) ions are
transferred from the chaperone Atox1 to the Wilson
disease protein (ATP7B) for incorporation into Cu-
dependent enzymes in the secretory pathway. Human
ATP7B is a large multi-domain membrane-spanning
protein which, in contrast to homologues in other
organisms, has six similar cytoplasmic metal-binding
domains (MBDs). The reason for multiple MBDs is
proposed to be indirect modulation of enzymatic
activity and it is thus intriguing that point mutations in
MBDs can promote Wilson disease. We here inves-
tigated, in vitro and in silico, the biophysical conse-
quences of clinically-observed Wilson disease
mutations, G85V in MBD1 and G591D in MBD6,
incorporated in domain 4. Because G85 and G591
correspond to a conserved Gly found in all MBDs, we
introduced the mutations in the well-characterized
MBD4. We found the mutations to dramatically
reduce the MBD4 thermal stability, shifting the
midpoint temperature of unfolding by more than
20 C. In contrast to wild type MBD4 and MBD4D,
MBD4V adopted a misfolded structure with a large b-
sheet content at high temperatures. Molecular
dynamic simulations demonstrated that the mutations
increased backbone fluctuations that extended
throughout the domain. Our findings imply that
reduced stability and enhanced dynamics of MBD1
or MBD6 is the origin of ATP7B dysfunction in
Wilson disease patients with the G85V or G591D
mutation.
Keywords Wilson disease  ATP7B Metal-binding
domain  Thermal stability  Circular dichroism 
Molecular dynamics
Introduction
Copper (Cu) is found in the active sites of many
essential proteins that participate in key cellular
reactions (Huffman and O’Halloran 2001; Puig and
Thiele 2002; Harris 2003). However, free Cu ions are
potentially toxic for cells since they are capable of
producing reactive oxygen species which results in
oxidative deterioration of biological molecules (Valko
et al. 2005). To avoid Cu toxicity, the intracellular
concentration of Cu is regulated via dedicated
proteins that facilitate uptake, efflux as well as
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distribution of Cu to Cu-dependent proteins and
enzymes (Festa and Thiele 2011; O’Halloran and
Culotta 2000; Robinson and Winge 2010). In the
human cytoplasm, after the uptake of Cu ions (Ohrvik
and Thiele 2014), the Cu chaperone Atox1 transports
the metal to the membrane-bound ATP7A and ATP7B
(Menke’s and Wilson disease proteins, respectively),
two homologous P1B-type ATPases located in the
trans-Golgi network. Once transferred to ATP7A/B,
the Cu ion is channeled to the lumen of the Golgi
where it is loaded onto specific Cu-dependent proteins
and enzymes.
ATP7A/B are multi-domain membrane proteins
with six cytoplasmic metal-binding domains (MBDs)
connected by peptide linkers of various lengths
constituting the N-terminal tail (Lutsenko et al.
2007). Each MBD in ATP7A/B, as well as Atox1,
has a ferredoxin-like a/b fold and a surface-exposed
invariant CXXC motif (X = any residue) in which a
single Cu can bind to the cysteine sulfurs. In contrast
to humans, bacterial and yeast P1B-type ATPases have
only one or two MBDs. The reason for the presence of
multiple MBDs in ATP7A/B has been proposed to be
connected with the regulation of Cu transfer to the
Golgi lumen and Cu-mediated protein trafficking
between the Golgi and the plasma membrane (Forbes
et al. 1999; LeShane et al. 2010; Hasan et al. 2012;
Huang et al. 2014). During the catalytic cycle which
requires ATP hydrolysis and transient phosphoryla-
tion, ATP7A/B are likely to undergo significant
conformational changes and changes in domain–
domain interactions (Lutsenko et al. 2007). Since
there is no high-resolution structural information on
the arrangement of the six MBDs within full length
ATP7A/B, it is unclear how these domains are
arranged relative to each other at different stages of
the catalytic cycle. Because Atox1 can deliver Cu to
the MBDs (Pufahl et al. 1997; Wernimont et al. 2000;
Achila et al. 2006; Banci 2006, 2008, 2009a, 2009b),
one may speculate that Cu-triggered conformational
changes among these domains might initiate the
catalytic cycle upon Atox1-mediated Cu delivery
(Mondol et al. 2016). Nonetheless, it remains unclear
if the direct path for Cu goes through the MBDs or, if
Atox1, like its bacterial homolog (Gonzalez-Guerrero
and Arguello 2008), delivers Cu directly to a binding
site at the membrane-spanning parts of ATP7A/B. It
has been shown in vitro that several MBDs can be
deleted/mutated without loss of Cu transport activity,
but the presence of at least one MBD appears to be
required (Forbes et al. 1999; Morin et al. 2009).
Mutations in ATP7B constitute the basis of Wilson
disease, a genetic disorder where Cu accumulates in
tissues, often resulting in neurological or psychiatric
symptoms together with liver dysfunction (Thomas
et al. 1995; Gitlin 2003). Over 300 missense mutations
in ATP7B have been described in different patients
(Huster et al. 2012), with the most common mutation
being H1069Q (Caca et al. 2001; Rodriguez-Granillo
et al. 2008). Taken into account the proposed indirect
role of theMBDs for ATP7B function, it is noteworthy
that at least 3 disease-causing missense mutations
have been located in the MBDs: G85V in MBD1;
L492S in MBD5; and G591D in MBD6 (Hamza et al.
1999; Hsi et al. 2008) with all three residues being
strictly conserved. Using a functional assay in yeast,
the introduction of G85V or L492S mutations was
found to result in an inactive ATP7B (Huster 2012).
Therefore, it has been suggested that these MBD
mutations will cause domain instability (Hamza et al.
1999), but this has not been tested experimentally.
L492 is situated in the core of the fifth metal binding
domain and mutation at this position can clearly have
dramatic structural effects. In contrast, G85 and G591
correspond to a conserved Gly found in all six MBDs
(Hamza et al. 1999) situated in a surface-exposed turn
opposite to the Cu binding site (Fig. 1). The predicted
effects of mutations at this position are still unclear as
one may argue that a loop residue would not be
particularly important for the overall domain stability.
To investigate the biophysical impact of mutations
of the conserved Gly in the MBDs, we here mutated
the corresponding Gly (G386) in MBD4 (which we
have characterized extensively previously (Niemiec
et al. 2012, 2014, 2015)) to Val (V) and Asp (D) and
compared the resulting variants to the wild-type
protein in vitro and in silico. We discovered that both
variants have dramatically lower thermal stability in
parallel with increased structural dynamics as com-
pared to the wild-type MBD4.
Materials and methods
Protein preparation
MBD4 wild-type construct in a pET21b vector
(Niemiec et al. 2012, 2015) was transformed into
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BL21 (DE3) plysS (Novagen) cells. Transformants
were first grown to an OD600 of 0.6, and then induced
with 1 mM isopropyl b-D-1-thiogalactopyranoside
(IPTG) and grown overnight at 25 C. The cells were
lysed using sonication in 20 mM Tris–HCl buffer pH
8.0 with 2 mM 1,4-Dithiothreitol (DTT) and in the
presence of protease inhibitor cocktail (Roche). The
centrifuged lysate was loaded onto 5 mLHiTrap QHP
anion exchange column (GE Healthcare) and was
eluted by linear gradient with 1 M NaCl in 20 mM
Tris–HCl buffer pH 8.0 with 2 mM DTT. The
fractions containing MBD4 were combined and con-
centrated with Ultra-15 Ultracel 3 K centrifugal filter
devices. The concentrate was loaded onto Hiload
16/600 Superdex 75 column (GE Healthcare) and
retrieved in 10 mMTris–HCl buffer pH 8.0 and 1 mM
DTT. For MBD4D (MBD4 with G386D mutation,
corresponding to G591D in MBD6) and MBD4V
(MBD4 with G386V mutation, corresponding to
G85V in MBD1), tagged versions (several tags
including a repressor protein and a His-stretch with a
Caspase 7 cleavage site) in pET3a constructs were
transformed into BL21 (DE3) plysS (Novagen) cells,
which were then grown in similar culturing conditions
as used for the wild-type MBD4. The cells were
harvested by centrifugation, re-suspended in Buffer A
(20 mM Tris–HCl pH 8, 50 mM NaCl and 2 mM
DTT) and stored at -80 C. For purification, the cell
suspension was thawed and a protease inhibitor
cocktail was added. After incubation on ice for
30 min, the cells were sonicated and centrifuged.
The supernatant was filtered through a 0.2 lm filter
and applied to 5 mL Hi Trap Ni–NTA column (GE
healthcare). After washing the column with 5 column
volume of buffer A containing 40 mM imidazole, the
protein was eluted with buffer A having 250 mM
imidazole. The tag was cleaved by adding Caspase 7 at
the ratio of 1:100 (caspase 7: MBD4 mutant w/w) in
the presence of 20 mM b-Mercaptoethanol and incu-
bated overnight at 4 C. The cleaved protein was then
loaded onto a 5 mL HiTrap Q HP anion exchange
column (GE Healthcare) and was eluted by linear
gradient with buffer A containing 1 M NaCl. The
eluted fractions were pooled, concentrated and loaded
onto a Hiload 16/600 superdex 75 column (GE
Healthcare). The obtained pure protein was finally
stored at -80 C in 20 mM Tris–HCl buffer pH 8.0
with 50 mM NaCl and 1 mM DTT. For all purified
proteins, the sample purity was confirmed by a single
band on a SDS-PAGE gel (Fig. S1) and a single elution
peak in size exclusion chromatography. The concen-
tration of the proteins was determined using
e280 = 1490 M
-1 cm-1 (MBD4 has one Tyr).
Circular dichroism spectroscopy
Far-UV circular dichroism (CD) spectra of MBD4
wild type and variants (65 lM) in 20 mM Tris–HCl
buffer pH 8 and 50 mM NaCl were recorded using a
Chirascan CD spectrometer (Applied Photophysics) in
1 mm quartz cuvette at 6 C, with 1 nm steps, a
bandwidth of 1 nm and a time-per-point of 1 s. The
Fig. 1 Amino acid sequence and 3D structure of MBD4
variants. The color scheme of the primary sequences follows
that of 3D structure; secondary structures are differently
colored. Gly386 is presented as a sphere and the Cu-binding
Cys are shown in stick representation
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spectra were averaged 5 times and baseline subtracted.
The thermal unfolding of the proteins (65 lM) was
monitored at 222 nm in stepped ramp mode from 6 to
98 C (with a temperature-sensitive probe inserted
into the cuvette) with a bandwidth of 1 nm, 17 s per
data point, and three repeats for each set. Experiments
were performed in the absence and presence of
equimolar amounts of copper to WD4. A fivefold
molar excess of DTT to protein was maintained in all
experiments in order to facilitate copper reduction
prior to protein loading. The reversibility of protein
thermal denaturation was tested by CD-monitored
cooling experiments and incubation at fixed temper-
atures. The CD data sets are reported as mean residue
molar ellipticity (degrees M-1 m-1).
Molecular dynamics simulations and analysis
The systems for molecular dynamics (MD) simula-
tions were prepared based on the solution struc-
ture 2ROP (the two-domain construct MBD3-MBD4
of human ATP7B) (Banci et al. 2008). The chain A of
2ROP, i.e., MBD4, was extracted as the target. The
structure was trimmed based on the sequence in Fig. 1.
The residue G386 of the wild type was exchanged in
silico to V386 and D386 to generate two MBD4
variants. In total we built 3 systems, namely wild type
MBD4, G386V-containing MBD4 (MBD4V) and
G386D-containing MBD4 (MBD4D). The hydrogens
were added to the proteins and the protonation states
were tuned at neutral pH conditions. The prepared
structure (wild type system as an example) was
solvated in a 66 Å rhombic dodecahedron TIP3P
water box (Jorgensen et al. 1983) to ensure 10 Å
buffer space between the protein atoms and the
boundary of the water box. 0.15 M of NaCl was
added to neutralize the system and mimic the phys-
iological conditions. The system was initially mini-
mized for 11,000 steps under a series of position
restraints and constraints, then heated to 300 K and
equilibrated under NVT condition (constant volume
and temperature) for 1 ns using the CHARMM
program (version 38a1) (Brooks 2009).
200 ns production MD simulation was carried out
at NPT condition (constant pressure and temperature)
for each system using the NAMD program (version
2.10) (Phillips et al. 2005). The pressure was con-
trolled by Nosé-Hoover Langevin piston method with
200 ps piston period and 100 ps piston decay time
(Feller et al. 1995). The temperature was maintained at
300 K by using Langevin thermostat with 5 ps friction
coefficient. Integration time step was set to 2 fs, which
is allowed through constraining any bond involving
hydrogens by SHAKE algorithm. Non-bonded van der
Waals energies were calculated using a switching
function with the switching distance from 9 to 11 Å
(Loncharich and Brooks 1989), and electrostatic
interactions were evaluated using the particle mesh
Ewald summation (PME) method (Petersen 1995).
The CHARMM36 force field (Best et al. 2012) with
the CMAP correction (MacKerell et al. 2004) was
used to present the proteins. In addition to the
simulations at 300 K, MBD4 and MBD4V were also
simulated for 200 ns at 330 K using the same protocol
as above. The covariance matrix analysis, principle
component analysis (PCA) (Brooks et al. 1995) and
geometric measurements on the simulated systems
were fulfilled in CHARMM routines. All the figures of
the protein structures were prepared by the PyMOL
graphic software (PyMOL version 0.99, DeLano
Scientific LLC, CA).
Results
Secondary structure and thermal stability in vitro
The far-UV CD spectrum at 6 C of wild-type MBD4
displayed a broad negative band at around 222 nm
indicating a mixture of b-sheet and a-helix structures
(Fig. 2a), as expected for a ferredoxin-like structure
(Banci et al. 2008). TheMBD4V andMBD4Dmutants
also showed characteristic CD spectra of folded
structures, very similar to the spectrum of the wild-
type protein. MBD4V showed a somewhat more
pronounced CD band at 208 nm (that reports on a-
helical content) as compared to the other two variants.
Thermal unfolding experiments of the apo-forms of
the variants probed by CD at 222 nm demonstrated
that the wild-type protein unfolded in a partly
reversible process, whereas MBD4D unfolded irre-
versibly (Figs. 3a, S2). The MBD4V variant had a
different thermal unfolding profile in which unfolding
was followed by refolding into a different structure
(Figs. 3a, 4). The first change upon increasing the
temperature was unfolding, as reflected in a decreased
absolute CD signal at 222 nm. Above 50 C, unfold-
ing was followed by a significant gain of secondary
30 Biometals (2017) 30:27–35
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structure as reflected by an increased absolute CD
signal at 222 nm (Fig. 3a). CD spectra at different
temperatures during heating of MBD4V showed that
at 48 C, the spectrum was characteristic of a
partially-unfolded protein, whereas at higher temper-
atures, the spectrum was indicative of b-sheet struc-
ture (Fig. 4). We note that heating-induced protein
misfolding into structures with large secondary struc-
ture content has previously been documented for other
proteins (Pozdnyakova and Wittung-Stafshede 2010;
Sedlak et al. 2008).
Despite the anomalous misfolding of the MBD4V
variant, it is clear that both mutants had dramatically
lower thermal stability (defined as the temperature at
which the folded structure is lost) than the wild-type



























































Fig. 2 CD spectra of MBD4D (red), MBD4V (blue), and MBD4 wild-type (black): a without Cu, and b in the presence of Cu in a 1:1
molar ratio of metal to protein



























































Fig. 3 Thermal unfolding profiles of MBD4D (red), MBD4V
(blue), and MBD4 (black). without Cu (a) and in the presence of
Cu in a 1:1 molar ratio (b) probed by CD at 222 nm. Circles
indicate estimated midpoints of the unfolding transitions (the
first transition for MBD4V)





























5 °C after melting
Fig. 4 CD spectra of MBD4V at 10 C (blue), 48 C (purple),
98 C (red), and, upon re-cooling of heated sample, at 5 C
(yellow)
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MBD4 (Fig. 3a). We estimated the thermal midpoints
(Tm)of themutant unfolding transitions tobe in the range
of 40–50 C (i.e., where 50 % of the protein sample is
unfolded), whereas wild-type MBD4 had a thermal
midpoint above 75 C. Thus, even though the mutations
are located in a loop at the surface of the folded protein
(Fig. 1), they have pronounced effects on the overall
thermal stability of the MBD4 structural fold.
Both mutants, like the wild-type domain (Niemiec
et al. 2012, 2015), coordinated Cu stoichiometrically
when mixed in micromolar concentrations in the
presence of 5-fold excess DTT. This is reasonable
since the mutation site is opposite to the Cu-binding
site. The spectra of the holo-forms are similar to those
of the apo-forms with only small changes in the CD
intensity (Fig. 2b). Thermal denaturation experiments
demonstrated that, when Cu was loaded onto the
protein, the Tm of the unfolding reactions decreased
for all the variants by 5–10 C at our conditions when
compared to the apo-forms (Fig. 3b). Thermal unfold-
ing reactions of Cu-loaded proteins were, like for the
apo-forms, partially reversible for wild-type MBD4
but irreversible for the mutants, based on CD data
collected upon cooling (Fig. S3). The increase of the
absolute CD value at 222 nm seen at higher temper-
atures for apo-MBD4V was not observed for the holo-
form of MBD4V. However, the spectrum of holo-
MBD4V after re-cooling was, as in the case of apo-
MBD4V, characteristic of b-sheet structure (Fig. S3).
Structural dynamics and protein motion in silico
To probe the influence of the mutations at atomistic
level, we performed 200 nsMDsimulations for each of
MBD4, MBD4V and MBD4D in apo-forms. Because
all-atom simulations of complete protein folding/
unfolding processes at room temperature are still
computationally challenging (Scheraga et al. 2007) we
here focused on variations in local structural dynamics
and motions of the folded protein domain. Unless
specified, analyses are based on simulations at 300 K.
The root-mean-square-deviation (RMSD) profiles
showed that MBD4V and MBD4D, especially
MBD4D, experienced more pronounced structural
deviations than MBD4 (Fig. 5a). The RMSD of
MBD4D periodically deviated 2.5 Å away from its
minimized solution structure after 50 ns, suggesting a
substantial perturbation induced by the introduced Asp
at position 386. The root-mean-square fluctuation
(RMSF) profiles located the perturbed regions, which
corresponded to the residues around the mutated 386
position (the loop connecting a1 and b2) and part of b2
ranging from residue 403 to 410 (Fig. 5b). The
secondary structure analysis also showed that MBD4D
had lost b structure (Fig. S4a–c) which was attributed
to the distortion of b2 (Fig. S4d). Taken together,
there is augmented structural dynamics in silico upon
mutation at position 386, with an Asp substitution
causing more distortion than a Val substitution.
To explore how the mutations influence protein
motions, we employed covariance matrix analysis and
PCA. Two major differences in the correlated motions
between the wild-type MBD4 and two variants were
found. First, pair-wised correlations along the matrix
diagonal were strengthened in MBD4V and MBD4D
as compared with in MBD4. Second, the mutations
produced enhanced anti-correlations throughout the
whole MBD4V and MBD4D structures (Fig. 6a–c).
The structural regions whose anti-correlations were
mostly enhanced (boxed in Fig. 6) in MBD4V and
MBD4D corresponded roughly to helices a1 and a2.
The enhanced motions included shearing and breath-
ing motions of the two helices and were structurally
captured by PCA (arrows, Fig. S5). Pronounced
motions may make structural units, such as a1 and
a2, more prone to large-scale conformational changes.
To trace the origin of MBD4V’s misfolding at high
temperatures found in vitro, we also performed MD
simulations on MBD4 and MBD4V at 330 K. During
these simulations, MBD4V underwent larger fluctua-
tions than wild type MBD4 (Fig. S5). After 120 ns,
MBD4V experienced a significant deviation relative
to its original structure (Fig. S6a), suggesting large-
scale conformational changes taking place. The RMSF
profile showed that structural changes occurred in the
end of a1 and in the loop between a1 and b1
(Fig. S6b). Investigation of the trajectory showed that
MBD4V had lost part of a1, resulting in an extended
loop between a1 and b1 (Fig. S6c, d). This elongated
loop may facilitate the transition to the b-sheet-rich
structure (as found experimentally).
Discussion
The mutations G85V and G591D result in Wilson
disease in multiple affected family members (Loudi-
anos et al. 1998). Because this position is highly
32 Biometals (2017) 30:27–35
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conserved among the human MBDs, this Gly residue,
despite its surface-located position, must be important
for the overall ATP7B function in vivo. The question is
why and how this is explained. Our experiments
demonstrate that mutation of this Gly to Val or Asp in
MBD4 creates pronounced domain thermal destabi-
lization in vitro and enhanced domain structural
dynamics in silico. All MBD4 variants are stable (i.e.,
folded and capable of binding Cu) at temperatures
below10 Cbut the twomutants unfold at considerably
lower temperatures as compared to wild type MBD4.
The lowered thermal stability of themutants (regardless
of Cu loading or not) and the irreversibility of the
reactions suggest that, at physiological temperatures,
such mutated domains will be largely unfolded. The
observation thatMBD4Vmisfolded into a newb-sheet-
rich species at high temperatures indicates that the
MBD structural unit is prone to alternate structures and
that a small increase in hydrophobicity, such as upon
introducing a Val, may act as a trigger.
Although several Wilson disease mutations result in
defects in ATP7B trafficking, ATP7B proteins with a
G85VorG591Dmutationwere reported to have normal
cellular localization (although this has been questioned
(de Bie et al. 2007)), but they appear to be expressed at
lower levels (de Bie et al. 2007; van den Berghe et al.
2009) and have impaired interactions with Atox1 in
model systems (Hamza et al. 1999). If conformational
changes are strongly coupled among the six MBDs, or/
and between MBDs and other domains in ATP7B,
partial/full unfolding and/or increased structural
dynamics of an individual MBD may cause overall
Fig. 5 Structural deviation and fluctuation of MDB4 proteins.
a Backbone RMSD profiles of MBD4, MBD4V and MBD4D
(black, blue and red, respectively). The smoothed curves are
shown together with their corresponding RMSD curves.
b Heavy atom RMSF profiles with the same color scheme as
in (a)
Fig. 6 Covariance matrices of MBD4 (a), MBD4V (b) and
MBD4D (c) with the X and Y axes reporting on residue ID. The
color scale changes from blue (-0.6 and smaller correlation
value) for anti-correlation to green (zero) for non-correlation
and to red (0.6 and greater correlation value) for correlation
between a pair of residues
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protein dysfunction, although occurring distant from
the functional sites. Molecular studies of full-length
proteins harboring these mutations are required to
reveal what functional step(s) (e.g., Cu uptake from
Atox1, ATP binding and/or hydrolysis, Cu movement
along the MBDs or through the membrane channel,
vesicle trafficking) are primarily affected byMBD1and
MBD6 instability. It is also important to assess if
unfolding of onemutated domain within the full-length
protein remains a local phenomenon, or if this triggers
unfolding of other domains as well, resulting in wide-
spread perturbation of the protein.
Interestingly, both G85V and G591D mutated
ATP7B variants were found to have increased
COMMD1 interactions (de Bie et al. 2007). It has
been proposed that COMMD1 is a negative regulator
of protein stability and its binding to the two ATP7B
variants may thus be part of the cellular quality control
system (de Bie et al. 2007). In vivo, COMMD1
interactions may block ATP7B Cu-transport activity
and/or direct ATP7B for degradation. Thus one
scenario is that instability/unfolding of MBD1 or
MBD6 triggers COMMD1 binding that, in turn,
sterically block Cu transport activity of the protein.
In summary, introducing a larger amino acid (Asp
or Val instead of Gly) at position 386 in MBD4 (as
found inMBD1 andMBD6 inWilson disease patients)
results in enhanced domain structural dynamics in
silico and decreased resistance towards thermal per-
turbations in vitro. Our findings suggest that these two
mutations cause Wilson disease in patients because of
MBD structural instability that indirectly or directly
affects domain–domain interactions in ATP7B which,
in turn, impair the overall Cu-transport function.
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